GORDON MICHAEL S

10% Owner Gordon Michael S buys 93,223 shares at $1.25 avg; stock at $31.00 vs. 52-wk high $70.25

Gordon Michael S, a 10% owner, executed 2 separate purchases totaling 93,223 shares for $116,880.03 at a blended average price of $1.25 on 2024-09-16 and 2024-09-17. The stock currently trades at $31.00, representing a 55.9% decline from its 52-week high of $70.25, and is down 20.0% over the past 90 days. His prior trade at PMN (a buy on 2024-07-31) produced a -4.8% 30-day return, and his cross-ticker track record shows 1 prior buy with an average 30-day return of -4.8%. The company is unprofitable with a full-year net income of -$2,623,657.00. The timing of this accumulation follows a significant drawdown in stock price but occurs within an ongoing downtrend, and prior purchase patterns at this ticker have not yet demonstrated positive outcomes at measurable intervals.

10% owner Gordon Michael S acquired 465,116 shares of PMN, raising stake to 2.08M shares (+28.9%), as stock down 57.1% from 52-week high amid cluster buy pattern

Gordon Michael S, a 10% owner of ProMIS Neurosciences, purchased 465,116 shares on 2024-07-31, expanding his holdings by 28.9% to 2,075,629 shares post-transaction. This buy occurs within a cluster pattern where 2 other insiders also purchased within the past 14 days, suggesting coordinated confidence at a time when the stock trades -57.1% from its 52-week high of $77.50 and has declined 32.1% over the past 90 days. The company reported a net loss of $-3,635,088 over its most recent full fiscal year, meaning the purchase comes amid unprofitable operations. The derivative-conversion flag indicates this transaction involves a conversion of derivative securities rather than a straightforward open-market buy; the insider's complete position cannot be assessed from Table I alone, and investors should review Table II derivative holdings for full context.